| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 16 | 2023 | 499 | 2.210 |
Why?
|
| Echocardiography, Doppler | 10 | 2018 | 134 | 1.360 |
Why?
|
| Heart Ventricles | 13 | 2023 | 264 | 1.280 |
Why?
|
| Ventricular Function, Left | 10 | 2019 | 269 | 1.180 |
Why?
|
| Ventricular Dysfunction, Left | 11 | 2020 | 165 | 1.160 |
Why?
|
| Sepsis | 2 | 2019 | 286 | 0.920 |
Why?
|
| Electrocardiography | 10 | 2019 | 553 | 0.900 |
Why?
|
| Head and Neck Neoplasms | 2 | 2016 | 168 | 0.860 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2017 | 49 | 0.840 |
Why?
|
| Stroke Volume | 11 | 2018 | 331 | 0.830 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 255 | 0.820 |
Why?
|
| Echocardiography, Transesophageal | 10 | 2006 | 109 | 0.690 |
Why?
|
| Situs Inversus | 1 | 2019 | 5 | 0.630 |
Why?
|
| Dextrocardia | 1 | 2019 | 5 | 0.630 |
Why?
|
| Shock, Septic | 2 | 2019 | 86 | 0.590 |
Why?
|
| Pulmonary Embolism | 2 | 2017 | 171 | 0.580 |
Why?
|
| Aged | 43 | 2019 | 14258 | 0.560 |
Why?
|
| Systole | 7 | 2019 | 109 | 0.550 |
Why?
|
| Dilatation | 1 | 2016 | 32 | 0.520 |
Why?
|
| Medical Audit | 1 | 2016 | 60 | 0.520 |
Why?
|
| Hyperkalemia | 1 | 2016 | 20 | 0.520 |
Why?
|
| Risk Adjustment | 1 | 2016 | 93 | 0.510 |
Why?
|
| Humans | 70 | 2023 | 62930 | 0.510 |
Why?
|
| Potassium | 1 | 2016 | 101 | 0.510 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2016 | 45 | 0.500 |
Why?
|
| Pacemaker, Artificial | 2 | 2013 | 49 | 0.500 |
Why?
|
| Diastole | 7 | 2016 | 91 | 0.490 |
Why?
|
| Electroencephalography | 1 | 2016 | 147 | 0.490 |
Why?
|
| Benchmarking | 1 | 2016 | 138 | 0.490 |
Why?
|
| Female | 52 | 2020 | 32571 | 0.470 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2023 | 44 | 0.470 |
Why?
|
| Middle Aged | 37 | 2017 | 17389 | 0.460 |
Why?
|
| Heart Rate | 6 | 2012 | 321 | 0.460 |
Why?
|
| Takotsubo Cardiomyopathy | 4 | 2020 | 65 | 0.450 |
Why?
|
| Male | 43 | 2019 | 29582 | 0.440 |
Why?
|
| Myocardial Infarction | 5 | 2015 | 910 | 0.440 |
Why?
|
| Tracheostomy | 1 | 2014 | 36 | 0.430 |
Why?
|
| Atrial Fibrillation | 4 | 2016 | 835 | 0.420 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 123 | 0.420 |
Why?
|
| Heart Neoplasms | 5 | 2006 | 36 | 0.420 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2013 | 5 | 0.410 |
Why?
|
| Hepatic Veins | 1 | 2013 | 13 | 0.410 |
Why?
|
| Aortic Valve Stenosis | 3 | 2016 | 188 | 0.390 |
Why?
|
| Postoperative Complications | 2 | 2016 | 1290 | 0.380 |
Why?
|
| Pulmonary Artery | 1 | 2013 | 95 | 0.380 |
Why?
|
| Myocardial Contraction | 3 | 2009 | 88 | 0.380 |
Why?
|
| Algorithms | 2 | 2016 | 1000 | 0.370 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2012 | 178 | 0.360 |
Why?
|
| Gated Blood-Pool Imaging | 2 | 2009 | 11 | 0.360 |
Why?
|
| Heart Atria | 6 | 2023 | 138 | 0.350 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2015 | 359 | 0.350 |
Why?
|
| Peripheral Arterial Disease | 1 | 2013 | 172 | 0.340 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2010 | 265 | 0.340 |
Why?
|
| Pericardial Effusion | 1 | 2010 | 21 | 0.340 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2010 | 33 | 0.330 |
Why?
|
| Aortic Valve | 4 | 2011 | 190 | 0.330 |
Why?
|
| Hypertension, Pulmonary | 2 | 2008 | 96 | 0.330 |
Why?
|
| Metoprolol | 1 | 2009 | 14 | 0.320 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2006 | 26 | 0.320 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2009 | 151 | 0.310 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2002 | 42 | 0.310 |
Why?
|
| Blood Pressure | 4 | 2010 | 506 | 0.300 |
Why?
|
| Cardiac Catheterization | 4 | 2014 | 279 | 0.300 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 202 | 0.300 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2008 | 28 | 0.290 |
Why?
|
| Cardiac Volume | 1 | 2007 | 7 | 0.280 |
Why?
|
| Stress, Physiological | 2 | 2009 | 193 | 0.280 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 1636 | 0.280 |
Why?
|
| Ventricular Function | 1 | 2007 | 22 | 0.280 |
Why?
|
| Heart Failure | 7 | 2016 | 911 | 0.260 |
Why?
|
| Hypertension | 2 | 2009 | 582 | 0.260 |
Why?
|
| Electric Countershock | 3 | 2015 | 101 | 0.260 |
Why?
|
| Myxoma | 3 | 2006 | 13 | 0.250 |
Why?
|
| Sensitivity and Specificity | 7 | 2016 | 1138 | 0.250 |
Why?
|
| Acute Coronary Syndrome | 1 | 2009 | 253 | 0.250 |
Why?
|
| Heart Diseases | 3 | 2007 | 216 | 0.250 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2007 | 198 | 0.240 |
Why?
|
| United Kingdom | 2 | 2016 | 80 | 0.240 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 103 | 0.240 |
Why?
|
| Stress, Psychological | 2 | 2009 | 464 | 0.240 |
Why?
|
| Ventricular Remodeling | 3 | 2018 | 83 | 0.240 |
Why?
|
| Arrhythmia, Sinus | 1 | 2004 | 3 | 0.230 |
Why?
|
| Retrospective Studies | 11 | 2018 | 6557 | 0.230 |
Why?
|
| Heart Block | 1 | 2004 | 22 | 0.230 |
Why?
|
| Hypertrophy, Left Ventricular | 4 | 2012 | 124 | 0.230 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2016 | 26 | 0.220 |
Why?
|
| Triglycerides | 1 | 2005 | 243 | 0.220 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 5405 | 0.210 |
Why?
|
| Heart Valve Prosthesis | 2 | 2002 | 111 | 0.200 |
Why?
|
| Viridans Streptococci | 1 | 2002 | 5 | 0.200 |
Why?
|
| Streptococcal Infections | 1 | 2002 | 80 | 0.190 |
Why?
|
| Adult | 16 | 2016 | 16665 | 0.190 |
Why?
|
| Abscess | 1 | 2002 | 78 | 0.190 |
Why?
|
| Coronary Angiography | 4 | 2010 | 201 | 0.180 |
Why?
|
| Chest Pain | 2 | 2019 | 84 | 0.180 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2000 | 7 | 0.170 |
Why?
|
| Collateral Circulation | 1 | 2000 | 27 | 0.170 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2020 | 7 | 0.170 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 1999 | 2 | 0.160 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2004 | 56 | 0.160 |
Why?
|
| Risk Factors | 7 | 2016 | 5313 | 0.160 |
Why?
|
| Lymphoma | 1 | 2000 | 101 | 0.160 |
Why?
|
| Heart Aneurysm | 1 | 1999 | 23 | 0.160 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 26 | 0.160 |
Why?
|
| Aneurysm, False | 1 | 1999 | 50 | 0.150 |
Why?
|
| Heart Valves | 1 | 2018 | 25 | 0.150 |
Why?
|
| Abdominal Pain | 1 | 2019 | 101 | 0.150 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 116 | 0.150 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1999 | 85 | 0.150 |
Why?
|
| Aging | 2 | 2003 | 738 | 0.150 |
Why?
|
| Mitral Valve | 3 | 2004 | 117 | 0.150 |
Why?
|
| Aortic Diseases | 2 | 2011 | 73 | 0.150 |
Why?
|
| Risk Assessment | 3 | 2015 | 2055 | 0.150 |
Why?
|
| Ultrasonography | 4 | 2009 | 479 | 0.150 |
Why?
|
| Treatment Outcome | 4 | 2016 | 5597 | 0.140 |
Why?
|
| Heart Valve Diseases | 1 | 2018 | 92 | 0.140 |
Why?
|
| Dobutamine | 2 | 1994 | 10 | 0.140 |
Why?
|
| Prognosis | 5 | 2009 | 1727 | 0.140 |
Why?
|
| Massachusetts | 7 | 2016 | 2068 | 0.140 |
Why?
|
| Reference Values | 3 | 2007 | 335 | 0.140 |
Why?
|
| Cough | 1 | 2019 | 180 | 0.140 |
Why?
|
| Thallium Radioisotopes | 3 | 1995 | 9 | 0.130 |
Why?
|
| Cardiomegaly | 1 | 2016 | 34 | 0.130 |
Why?
|
| Pattern Recognition, Automated | 1 | 2016 | 53 | 0.130 |
Why?
|
| Catheterization | 1 | 1997 | 111 | 0.130 |
Why?
|
| Mitoxantrone | 1 | 2016 | 16 | 0.130 |
Why?
|
| ROC Curve | 1 | 2016 | 280 | 0.120 |
Why?
|
| Incidence | 3 | 2016 | 1370 | 0.120 |
Why?
|
| Prosthesis-Related Infections | 1 | 1996 | 34 | 0.120 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1997 | 62 | 0.120 |
Why?
|
| Mitral Valve Stenosis | 1 | 1995 | 15 | 0.120 |
Why?
|
| Parotid Neoplasms | 1 | 2014 | 4 | 0.120 |
Why?
|
| Bundle-Branch Block | 1 | 1994 | 15 | 0.120 |
Why?
|
| Pilot Projects | 2 | 2016 | 999 | 0.120 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2014 | 20 | 0.110 |
Why?
|
| Machine Learning | 1 | 2016 | 175 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 1996 | 127 | 0.110 |
Why?
|
| Tachycardia, Sinus | 1 | 1994 | 3 | 0.110 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 42 | 0.110 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2014 | 62 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 931 | 0.110 |
Why?
|
| Logistic Models | 2 | 2016 | 1268 | 0.110 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 61 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2014 | 335 | 0.110 |
Why?
|
| Operative Time | 1 | 2014 | 91 | 0.110 |
Why?
|
| Primary Prevention | 1 | 2015 | 136 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 101 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 191 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 274 | 0.100 |
Why?
|
| Prevalence | 4 | 2010 | 1369 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 75 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 485 | 0.100 |
Why?
|
| Device Removal | 1 | 2013 | 64 | 0.100 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2013 | 111 | 0.100 |
Why?
|
| Age Factors | 2 | 2014 | 1553 | 0.090 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 99 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2016 | 3260 | 0.090 |
Why?
|
| Defibrillators, Implantable | 1 | 2015 | 265 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1595 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2009 | 2553 | 0.090 |
Why?
|
| Torsades de Pointes | 1 | 2010 | 6 | 0.090 |
Why?
|
| Catheter Ablation | 1 | 2012 | 153 | 0.090 |
Why?
|
| Long QT Syndrome | 1 | 2010 | 32 | 0.090 |
Why?
|
| Diclofenac | 1 | 2010 | 4 | 0.090 |
Why?
|
| Ibuprofen | 1 | 2010 | 15 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2010 | 62 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 113 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 965 | 0.080 |
Why?
|
| Angiocardiography | 1 | 2009 | 6 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 297 | 0.080 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 112 | 0.080 |
Why?
|
| Disease Progression | 3 | 2008 | 1156 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2010 | 174 | 0.080 |
Why?
|
| Follow-Up Studies | 6 | 2014 | 2448 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2009 | 1113 | 0.070 |
Why?
|
| Biomechanical Phenomena | 1 | 2009 | 265 | 0.070 |
Why?
|
| Syndrome | 2 | 2006 | 180 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2011 | 1347 | 0.070 |
Why?
|
| Conscious Sedation | 2 | 2004 | 38 | 0.070 |
Why?
|
| Contrast Media | 1 | 2010 | 420 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 863 | 0.070 |
Why?
|
| Observer Variation | 1 | 2007 | 213 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 1080 | 0.070 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2006 | 5 | 0.070 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2007 | 124 | 0.070 |
Why?
|
| Young Adult | 1 | 2016 | 4647 | 0.060 |
Why?
|
| Catecholamines | 1 | 2006 | 31 | 0.060 |
Why?
|
| Magnetics | 1 | 2005 | 53 | 0.060 |
Why?
|
| Ventricular Pressure | 1 | 2005 | 30 | 0.060 |
Why?
|
| Patient Selection | 1 | 2007 | 483 | 0.060 |
Why?
|
| Inpatients | 1 | 2008 | 303 | 0.060 |
Why?
|
| Time Factors | 3 | 2009 | 3739 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2010 | 711 | 0.060 |
Why?
|
| Video Recording | 1 | 2005 | 133 | 0.060 |
Why?
|
| Exercise Test | 3 | 1995 | 251 | 0.060 |
Why?
|
| Blood Flow Velocity | 2 | 2004 | 72 | 0.060 |
Why?
|
| Adenosine | 2 | 1995 | 78 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2005 | 496 | 0.050 |
Why?
|
| Pericarditis, Constrictive | 1 | 2003 | 3 | 0.050 |
Why?
|
| Coronary Disease | 2 | 2003 | 246 | 0.050 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2003 | 20 | 0.050 |
Why?
|
| Pericardium | 1 | 2023 | 35 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2007 | 417 | 0.050 |
Why?
|
| Hemodynamics | 4 | 2003 | 247 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2003 | 102 | 0.050 |
Why?
|
| Sex Factors | 1 | 2005 | 972 | 0.050 |
Why?
|
| Atrial Appendage | 1 | 2002 | 33 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2000 | 42 | 0.040 |
Why?
|
| Stroke | 1 | 2007 | 1185 | 0.040 |
Why?
|
| Radionuclide Imaging | 2 | 1995 | 120 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2003 | 142 | 0.030 |
Why?
|
| Coronary Vessels | 2 | 1995 | 118 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 1998 | 87 | 0.030 |
Why?
|
| Myocardial Stunning | 1 | 1996 | 6 | 0.030 |
Why?
|
| Child | 2 | 2011 | 4505 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1996 | 57 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 1997 | 82 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 58 | 0.030 |
Why?
|
| Electrodes | 1 | 1996 | 35 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 2562 | 0.030 |
Why?
|
| Length of Stay | 2 | 2010 | 806 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2003 | 1535 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 1994 | 77 | 0.030 |
Why?
|
| Perfusion | 1 | 1994 | 72 | 0.030 |
Why?
|
| Heart | 1 | 1996 | 281 | 0.030 |
Why?
|
| Linear Models | 1 | 1995 | 406 | 0.030 |
Why?
|
| Coronary Artery Bypass | 2 | 2010 | 295 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 842 | 0.030 |
Why?
|
| Movement Disorders | 1 | 2013 | 23 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 1994 | 117 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 1114 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2012 | 38 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 171 | 0.020 |
Why?
|
| Acute Disease | 1 | 1994 | 671 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 1992 | 68 | 0.020 |
Why?
|
| Biomarkers | 2 | 2010 | 1382 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 638 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 659 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 135 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2010 | 167 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 101 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2010 | 167 | 0.020 |
Why?
|
| Oxygen | 1 | 1991 | 316 | 0.020 |
Why?
|
| Kidney | 1 | 1991 | 440 | 0.020 |
Why?
|
| Research Design | 1 | 2010 | 572 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 750 | 0.020 |
Why?
|
| Cause of Death | 1 | 2008 | 221 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2007 | 185 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2006 | 45 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2006 | 126 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2007 | 578 | 0.020 |
Why?
|
| Reoperation | 1 | 2006 | 290 | 0.010 |
Why?
|
| Midazolam | 1 | 2004 | 12 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2006 | 169 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2004 | 36 | 0.010 |
Why?
|
| Technetium Tc 99m Sestamibi | 2 | 1995 | 33 | 0.010 |
Why?
|
| Anesthetics, Intravenous | 1 | 2004 | 26 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 156 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 211 | 0.010 |
Why?
|
| Pulmonary Veins | 1 | 2004 | 38 | 0.010 |
Why?
|
| Fentanyl | 1 | 2004 | 76 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 308 | 0.010 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2003 | 9 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2003 | 42 | 0.010 |
Why?
|
| Rhabdomyolysis | 1 | 2003 | 23 | 0.010 |
Why?
|
| Troponin I | 1 | 2003 | 36 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2003 | 140 | 0.010 |
Why?
|
| Necrosis | 1 | 2003 | 144 | 0.010 |
Why?
|
| Membranes | 1 | 2002 | 18 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 273 | 0.010 |
Why?
|
| Venae Cavae | 1 | 1998 | 2 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1998 | 33 | 0.010 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2000 | 170 | 0.010 |
Why?
|
| Thrombosis | 1 | 1998 | 199 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1995 | 69 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 308 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1995 | 415 | 0.010 |
Why?
|
| Radionuclide Ventriculography | 1 | 1994 | 5 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 1994 | 38 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 1994 | 52 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1994 | 174 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1995 | 727 | 0.010 |
Why?
|
| Forecasting | 1 | 1994 | 232 | 0.010 |
Why?
|
| Renal Circulation | 1 | 1991 | 13 | 0.010 |
Why?
|
| Peritonitis | 1 | 1991 | 36 | 0.010 |
Why?
|
| Swine | 1 | 1991 | 370 | 0.010 |
Why?
|
| United States | 1 | 2003 | 7779 | 0.000 |
Why?
|
| Animals | 1 | 1991 | 20583 | 0.000 |
Why?
|